Court Says Some Donors of Stem Cells Can Be Paid
By Andrew Pollack,
New York Times
| 12. 01. 2011
An appeals court says a law prohibiting payment for donated organs did not apply to stem cells extracted from circulating blood.
A federal appeals court ruling on Thursday could make it easier for patients with diseases like leukemia to find matching bone marrow donors.
The Court of Appeals for the Ninth Circuit said that a federal law prohibiting payment for donated organs did not apply to stem cells extracted from circulating blood.
“The statute does not prohibit compensation for donations of blood and the substances in it, which include peripheral blood stem cells,” Judge Andrew J. Kleinfeld wrote for a unanimous three-judge panel.
The lawsuit was brought against the federal government by a coalition that included patients seeking bone marrow transplants and MoreMarrowDonors.org, a nonprofit group that wants to offer donors $3,000 in scholarships, housing allowances or gifts to charities.
“Every year, nearly 3,000 Americans die because they cannot find a matching bone marrow donor,” Jeff Rowes, a lawyer at the Institute for Justice, which represented the plaintiffs, said. “Today’s decision will put a stop to this irrational prohibition...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
